Publication | Open Access
Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
30
Citations
13
References
2021
Year
CFZ shows potential for ameliorating AMR; however, additional studies are needed to define optimal time of administration.
| Year | Citations | |
|---|---|---|
Page 1
Page 1